Mazdutide: Research Profile, Dosages & Supplier Prices
Mazdutide is a glp-1/glucagon agonist compound with a molecular weight of ~4550 g/mol and a research half-life of extended, supporting once-weekly dosing in published trials. Mazdutide is a dual GLP-1 and glucagon receptor agonist peptide developed by Eli Lilly and Innovent Biologics, with published phase 2 data showing substantial weight reduction in Chinese and global trial populations. It is approved in China (2024-2025) for weight management, making it one of the newest pharmaceutical peptides to enter the research market.
Research Use Only (RUO). Not for human or veterinary use. Not medical advice.
| Sequence | GLP-1/glucagon dual agonist peptide (structure published in trial literature) |
| Formula | C210H322N46O67 (approximate) |
| Mol. weight | ~4550 g/mol |
| Half-life | Extended, supporting once-weekly dosing in published trials |
| Forms sold | Lyophilized vial (research) |
What is Mazdutide?
Research interest covers dual GLP-1/glucagon pharmacology - the same receptor pair targeted by survodutide - and comparative metabolic signaling.
As a newer molecule, mazdutide synthesis expertise is concentrated in fewer labs. Verify third-party COAs carefully; mislabeled GLP-1 substitutions are a known issue.
Mechanism of Action (Research Context)
Dual agonist at GLP-1 and glucagon receptors, studied for combined appetite suppression and energy expenditure effects.
Research Areas
Mazdutide Dosages in Research
Published clinical research titrated once-weekly doses up to 9mg in human trials. Laboratory research use only.
Dosage information is a summary of published laboratory research and is provided for informational purposes only. These compounds are not for human use.
Storage & Handling
Lyophilized: -20C. Reconstituted: 2-8C, use within 30 days.
Mazdutide Supplier Price Comparison
| Supplier | Product | Price | Score |
|---|---|---|---|
| Buy Peptides | Mazdutide (1 Vial) | $54.99 | ★ 2.3 |